|
Website：http://www.eso.net
8-9 May 2009, Tianjin , China
Chair: F. Cavalli, CH - X. Hao, CN
PRELIMINARY PROGRAMME
FRIDAY, 8 MAY
BREAST CANCER
8:30 Welcome and introduction: presentation of the programme
F. Cavalli, CH - X. Hao, CN
8:45 Breast Cancer: the main questions
L. Gianni, IT
9:00 Pathology of breast cancer
F. Symmans , US
9:45 Pathology of breast cancer in China
L. Fu, CN
10:15 Coffee break
10:45 Surgery of breast cancer
J. Zgajnar, SI
11:30 Surgery of breast cancer in China
L. Gu, CN
12:00 Surgery of breast cancer in China
Z. Shao, CN
12:30 Lunch break
13:30 Radiotherapy
H. Marsiglia, FR
14:15 Radiotherapy of breast cancer in China
Z. Yu, CN
14:45 Coffee break
15:15 Medical treatment of breast cancer
L. Gianni, IT
16:00 Medical treatment of breast cancer in China
Z. Jiang, CN
16:30 Biotherapy of breast cancer in China
X. Ren, CN
17:00 Roundtable and clinical cases discussion
|
SATURDAY, 9 MAY
LYMPHOMA/LEUKEMIAS
8:45 The main questions
F. Cavalli, CH
9:00 Molecular biology of lymphomas
R. Dalla Favera , US
10:00 Indolent lymphomas
F. Cavalli, CH
10:30 Radiotherapy of lymphomas in China
Y. Li, CN
11:00 Coffee break
11:30 Aggressive B-cell lymphomas
J.M. Vose, US
12:00 Aggressive B-cell lymphomas in China
H. Wang, CN
12:30 Roundtable and clinical cases discussion
13:15 Lunch break
14:15 Extranodal lymphomas
F. Cavalli, CH
14:45 T-cell lymphomas
J.M. Vose , US
15:15 Distinct distributions of subgroups, cytogenetic profiles and BCL2 expression mechanism of diffuse large B-cell lymphoma in Chinese and Western populations
X. Zhu，CH
15:45 CLL
F. Cavalli, CH
16:00 Coffee break
16:30 Acute leukemias
B. Lowenberg, NL
17:00 CML and myelodysplasia
B. Lowenberg, NL
17:30 Roundtable and clinical cases discussion
18:15 Closure
|
FACULTY
F. Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, CH
R. Dalla Favera, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, US
L. Fu, Tianjin Medical University Cancer Institute and Hospital, Tianjin, CN
L. Gianni, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, IT
L. Gu, Tianjin Medical University Cancer Institute and Hospital, Tianjin, CN
X. Hao, Tianjin Medical University Cancer Institute and Hospital, Tianjin, CN
Z. Jiang, 307 Hospital of PLA, Beijing, CN
Y. Li, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, CN
B. Lowenberg, Dept. Of Haematoloy, Erasmus University Medical center, Rotterdam, NL
H. Marsiglia, Institut Gustave-Roussy, Villejuif Cedex, FR
X. Ren, Tianjin Medical University Cancer Institute and Hospital, Tianjin, CN
Z. Shao, Breast Cancer Institute Fudan University Cancer Hospital, Shanghai, CN
F. Symmans, University of Texas M. D. Anderson Cancer, Houston, Texas, US
J.M. Vose, Nebraska Medical Center, Omaha, US
H. Wang, Tianjin Medical University Cancer Institute and Hospital, Tianjin, CN
Z. Yu, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, CN
X.Zhu, Shanghai Fudan Univeristy Cancer Hospital Shanghai, CN
J. Zgajnar, Institute of Oncology, Ljubljana, SI
|
